91 related articles for article (PubMed ID: 1723462)
1. Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure.
Ruilope LM; Guerrero L; Casal MC; Alcazar JM; Campo C; Mazuecos A; Fernandez ML; Rodicio JL
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S71-3. PubMed ID: 1723462
[TBL] [Abstract][Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
3. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
Sambhi MP
Angiology; 1988 Jan; 39(1 Pt 2):106-12. PubMed ID: 3341609
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of nitrendipine in the hypertensive patient with renal impairment.
Ruilope LM; Araque A; Lahera V; Suarez C
Ren Fail; 1993; 15(3):359-63. PubMed ID: 8516491
[TBL] [Abstract][Full Text] [Related]
5. Effects of felodipine in patients with refractory hypertension and progressive renal disease.
Herlitz H; Nyberg G; Granérus G; Björck S; Aurell M
Scand J Urol Nephrol Suppl; 1988; 108():31-4. PubMed ID: 3163828
[No Abstract] [Full Text] [Related]
6. Long-term treatment of essential arterial hypertension with nitrendipine.
Uslenghi E; Minelli M; Bo L; Avogliero G; Amerio S; Rocci R; Borgnino C
Clin Ther; 1988; 10(2):169-77. PubMed ID: 3273864
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
8. [Diclofurime: a new antihypertensive agent. Effectiveness and kidney tolerance].
Godin M; Fillastre JP; Revert C; Borsa F; Reumont G; Viotte G
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():79-89. PubMed ID: 6794531
[TBL] [Abstract][Full Text] [Related]
9. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term therapy with arotinolol on blood pressure and renal function in hypertensive patients with chronic renal failure.
Shiigai T
Clin Ther; 1993; 15(2):330-7. PubMed ID: 7686085
[TBL] [Abstract][Full Text] [Related]
11. [Clinical pharmacology of prazosin in arterial hypertension with chronic renal insufficiency].
Chaignon M; Le Roux E; Aubert P; Lucsko M; Flouvat B; Guédon J
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():71-7. PubMed ID: 6794530
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of nitrendipine.
Ruilope LM
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
[TBL] [Abstract][Full Text] [Related]
13. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure.
Marchais SJ; Boussac I; Guerin AP; Delavaux G; Metivier F; London GM
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S74-8. PubMed ID: 1723463
[TBL] [Abstract][Full Text] [Related]
14. Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure.
Marchais SJ; Boussac I; Guerin AP; Delavaux G; Metivier F; London GM
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S14-8. PubMed ID: 1725796
[TBL] [Abstract][Full Text] [Related]
15. Nitrendipine in patients with end-stage renal disease and hypertension.
Bambauer R; Jutzler GA; Weber U; Walter R; Keller HE
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S133-5. PubMed ID: 2468856
[TBL] [Abstract][Full Text] [Related]
16. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
Barenbrock M; Colmorgen U; Firschka E; Gellert J; Lippert J; Schröder K; Spieker C; Voigt-Ladner G; Wagner K; Neumayer HH
Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523
[TBL] [Abstract][Full Text] [Related]
18. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
Mengden T; Schubert M; Jeck T; Edmonds D; Vetter W
J Hypertens Suppl; 1990 Sep; 8(4):S91-4. PubMed ID: 1979615
[TBL] [Abstract][Full Text] [Related]
19. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
20. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
